Cargando…
Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET
Expression of the chemokine receptor CXCR4 by many cancers correlates with aggressive clinical behavior. As part of the initial studies in a project whose goal was to quantify CXCR4 expression on cancers non-invasively, we examined CXCR4 expression in cancer samples by immunohistochemistry using a v...
Autores principales: | Weiss, Ido D., Huff, Lyn M., Evbuomwan, Moses O., Xu, Xin, Dang, Hong Duc, Velez, Daniel S., Singh, Satya P., Zhang, Hongwei H., Gardina, Paul J., Lee, Jae-Ho, Lindenberg, Liza, Myers, Timothy G., Paik, Chang H., Schrump, David S., Pittaluga, Stefania, Choyke, Peter L., Fojo, Tito, Farber, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650270/ https://www.ncbi.nlm.nih.gov/pubmed/29088715 http://dx.doi.org/10.18632/oncotarget.19945 |
Ejemplares similares
-
Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET
por: Weiss, Ido D., et al.
Publicado: (2018) -
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
por: Fojo, Tito, et al.
Publicado: (2020) -
Plerixafor
por: Slater, Susan
Publicado: (2012) -
PET imaging of CXCR4 using copper-64 labeled peptide antagonist
por: Jacobson, Orit, et al.
Publicado: (2011) -
Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)